Invention Grant
- Patent Title: Compositions and methods for the treatment of meibomian gland dysfunction
-
Application No.: US16562374Application Date: 2019-09-05
-
Publication No.: US10772899B2Publication Date: 2020-09-15
- Inventor: Yair Alster , Omer Rafaeli , K. Angela MacFarlane , Cary Reich , Shimon Amselem , Doron Friedman
- Applicant: Azura Ophthalmics Ltd.
- Applicant Address: IL Tel Aviv
- Assignee: AZURA OPHTHALMICS LTD.
- Current Assignee: AZURA OPHTHALMICS LTD.
- Current Assignee Address: IL Tel Aviv
- Agency: Wilson Sonsini Goodrich & Rosati
- Main IPC: A61K31/60
- IPC: A61K31/60 ; A61K33/04 ; A61K9/00 ; A61K31/327 ; A61K8/23 ; A61K9/06 ; A61K31/122 ; A61K31/17 ; A61K31/19 ; A61K31/4015 ; A61K31/555 ; A61K35/04 ; A61K8/22
Abstract:
Described herein are compositions and methods for the treatment of meibomian gland dysfunction. Said compositions and methods comprise keratolytic agents, such as salicylic acid, selenium disulfide, or the like. Topical administration of said compositions to the eyelid margin or surrounding areas provides therapeutic benefit to patients suffering from meibomian gland dysfunction.
Public/Granted literature
- US20190388440A1 COMPOSITIONS AND METHODS FOR THE TREATMENT OF MEIBOMIAN GLAND DYSFUNCTION Public/Granted day:2019-12-26
Information query
